Patent · US Active

TRPV1 antagonists

US8604053B2 · kind B2 · utility

1Cited by

8References

32Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Arthur Gomtsyan · Vernon Hills, US
Eric A. Voight · Pleasant Prairie, US
Erol K. Bayburt · Gurnee, US
Jun Chen · Lake Bluff, US
Jerome F. Daanen · Racine, US
Stanley DiDomenico · Richmond, US
Michael E. Kort · Lake Bluff, US
Philip R. Kym · Libertyville, US
Heath A. McDonald · Wonder Lake, US
Richard J. Perner · Gurnee, US
Robert G. Schmidt · Waukegan, US

Key dates

Filing date	Oct 15, 2009
Grant date	Dec 10, 2013
Priority date	—
Expiry date	May 24, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compounds of formula (I) or pharmaceutically acceptable salts, solvates, prodrugs, salts of prodrugs, or combinations thereof,wherein R1, R2, R3, R4, and m are defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.